FDA Inspection 1249630 — Daniel Rutrick, MD
The FDA completed an inspection of Daniel Rutrick, MD on September 11, 2024 in Watertown, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 11, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Watertown, MA (United States)
Additional Details
Clinical Investigator (CI)